- Home
- BTMD vs OKYO Comparison
BTMD vs OKYO Comparison
Compare BTMD & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BTMD | OKYO |
|---|---|---|
| Founded | 2012 | 2007 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.4M | 79.7M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | BTMD | OKYO |
|---|---|---|
| Price | $2.19 | $2.02 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $6.00 | $6.00 |
| AVG Volume (30 Days) | 164.4K | ★ 322.9K |
| Earning Date | 03-11-2026 | 07-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 270.48 | N/A |
| EPS | ★ 0.78 | N/A |
| Revenue | ★ $195,645,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.37 | N/A |
| P/E Ratio | $2.88 | ★ N/A |
| Revenue Growth | ★ 1.34 | N/A |
| 52 Week Low | $2.03 | $1.01 |
| 52 Week High | $5.03 | $3.35 |
Technical Indicators
Market Signals| Indicator | BTMD | OKYO |
|---|---|---|
| Relative Strength Index (RSI) | 43.00 | 45.69 |
| Support Level | $2.08 | $1.82 |
| Resistance Level | $2.29 | $2.17 |
| Average True Range (ATR) | 0.13 | 0.22 |
| MACD | 0.01 | -0.04 |
| Stochastic Oscillator | 41.18 | 29.85 |
Price Performance
Historical ComparisonAbout BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.